India Anthrax Treatment Market Size & Outlook, 2025-2033


India Anthrax Treatment Market Insights

  • As per Reed Intelligence insights, the India Anthrax Treatment Market stood at USD 15.7 Million in 2024 and is anticipated to grow to USD 25 Million by 2033.
  • The India market is expected to advance at a CAGR of 5.26% from 2026 through 2033.
  • In 2024, Cutaneous Anthrax accounted for the highest share of the By Disease Type market size.
  • During the forecast period, Cutaneous Anthrax is set to register the highest growth, making it the most lucrative By Disease Type segment.

Other Key Findings


  • In 2024, India represented 3.72% of the overall global Anthrax Treatment Market size.
  • United States is projected to lead the global Anthrax Treatment Market size by 2033.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
  • Singapore is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 2.55 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 15.7 Million
Market Size In 2033 USD 25 Million
Largest segment Cutaneous Anthrax
Units Revenue in USD Million
CAGR 5.26% (2025-2033)
Segmnetation Covered
By Disease Type
  1. Cutaneous Anthrax
  2. Inhalation Anthrax
  3. Gastrointestinal Anthrax
  4. Injection Anthrax
By Treatment Type
  1. Antibiotics
  2. Immunoglobulins
  3. Others
By Route of Administration
  1. Parenteral
  2. Oral
By End-User
  1. Hospitals
  2. Clinics
  3. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports